WorldQuant Millennium Advisors’s Sarepta Therapeutics SRPT Stock Holding History

WorldQuant Millennium Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.07M	Sell	114,945 -99,642	-46%	-$1.88M	0.01%	510
2026 Q1	$4.67M	Buy	214,587 +184,630	+616%	+$3.57M	0.02%	343
2025 Q4	$645K	Buy	+29,957	New	+$631K	﹤0.01%	515
2021 Q2	–	Sell	-73,970	Closed	-$5.51M	–	404
2021 Q1	$5.51M	Buy	73,970 +50,228	+212%	+$4.63M	0.12%	231
2020 Q4	$4.05M	Sell	23,742 -31,510	-57%	-$4.67M	0.09%	253
2020 Q3	$7.76M	Buy	55,252 +22,767	+70%	+$3.46M	0.18%	168
2020 Q2	$5.21M	Buy	+32,485	New	+$4.42M	0.12%	211

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

WorldQuant Millennium Advisors's SRPT Position: Q2 2026 in Review

WorldQuant Millennium Advisors reduced its Sarepta Therapeutics (SRPT) stake by 46% in Q2 2026, selling an estimated $1.88M and leaving 114,945 shares worth $2.07M. The position accounts for 0.01% of the portfolio, ranked #510.

WorldQuant Millennium Advisors first reported a position in SRPT in Q2 2020 and has held it in 7 quarters since. The position peaked at $7.76M in Q3 2020. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

WorldQuant Millennium Advisors held 114,945 shares of Sarepta Therapeutics worth $2.07M as of Q2 2026.
WorldQuant Millennium Advisors sold 99,642 Sarepta Therapeutics shares in Q2 2026, an estimated $1.88M.
Sarepta Therapeutics made up 0.01% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #510 holding.
WorldQuant Millennium Advisors first reported a position in Sarepta Therapeutics in Q2 2020 and has held it in 7 quarters since.
WorldQuant Millennium Advisors's Sarepta Therapeutics position peaked at $7.76M in Q3 2020.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.